Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

Seeking Alpha

09 Jul 2026, 06:12 UTC · 3h ago

Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript

Which stocks this story touches

How each ticker is affected

TARS+0.00
The mention is a transcript header for an M&A call, which is neutral without further content.

Read original · https://seekingalpha.com/article/4920782-tarsus-pharmaceuticals-inc-tars-m-and-a-call-transcript

Free · No account

Track these names every morning.

Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.

We’ll watch

$TARS#biotech#call_transcript#m_and_a#pharmaceuticals

Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.

Free forever · one email a day, max · unsubscribe in one click.How it works

How the impact breaks down

Where the story's weight lands

Impact by category

Sector Rotation+0.200

6 related stories

Invezz
25m ago
AstraZeneca shares plunge as Wainua fails late-stage heart disease trial
- biotech
- pharmaceuticals
Read

Tarsus Pharmaceuticals, I… — TARS +0.00 | NewsImpactScreener

Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript

How each ticker is affected

Track these names every morning.

Impact by category

AstraZeneca shares plunge as Wainua fails late-stage heart disease trial

Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript

How each ticker is affected

Track these names every morning.

Impact by category

AstraZeneca shares plunge as Wainua fails late-stage heart disease trial

Biggest drivers

Most positively impacted

Most negatively impacted

Global PVDF Syringe Filters Market Set to Grow at 6.98% CAGR, Reaching USD 78.43 Million by 2032

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

ROSEN, A LONGSTANDING LAW FIRM, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ERAS

Hugo Boss Urges Shareholders to Reject Frasers' $2.2 Billion Takeover Bid

Hugo Boss recommends shareholders reject Frasers' bid

Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript

How each ticker is affected

Track these names every morning.

Impact by category

Next reads from the same story arc

AstraZeneca shares plunge as Wainua fails late-stage heart disease trial

Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript

How each ticker is affected

Track these names every morning.

Impact by category

Next reads from the same story arc

AstraZeneca shares plunge as Wainua fails late-stage heart disease trial

Biggest drivers

Most positively impacted

Most negatively impacted

Global PVDF Syringe Filters Market Set to Grow at 6.98% CAGR, Reaching USD 78.43 Million by 2032

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

ROSEN, A LONGSTANDING LAW FIRM, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ERAS

Hugo Boss Urges Shareholders to Reject Frasers' $2.2 Billion Takeover Bid

Hugo Boss recommends shareholders reject Frasers' bid